Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma.
作者信息
Gogna Nirdosh K, Duchesne Gillian, O'Brien Peter, Spry Nigel, Turner Sandra, Matthews John, Borg Martin, Bauman Kathryn, King Madeleine, Burmeister Elizabeth
机构信息
Radiation Oncology Services - Mater Centre, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
出版信息
J Med Imaging Radiat Oncol. 2018 Oct;62(5):668-670. doi: 10.1111/1754-9485.12752.
PMID:30288941
Abstract
摘要
相似文献
1
Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma.跨塔斯曼放射肿瘤学组癌症研究：III期 - 肌层浸润性膀胱癌试验（TROG 02.03）：一个道德困境。
J Med Imaging Radiat Oncol. 2018 Oct;62(5):668-670. doi: 10.1111/1754-9485.12752.
2
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.局部肌层浸润性膀胱移行细胞癌放疗期间每周同步低剂量顺铂的疗效和耐受性：跨塔斯曼放射肿瘤学组两项连续II期研究报告
Radiother Oncol. 2006 Oct;81(1):9-17. doi: 10.1016/j.radonc.2006.09.001. Epub 2006 Sep 28.
3
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03.采用放疗联合化疗选择性膀胱保留治疗浸润性膀胱癌患者的新辅助化疗Ⅲ期试验：放射肿瘤学组89-03的初步结果
J Urol. 1999 Aug;162(2):623-4. doi: 10.1016/s0022-5347(05)68645-4.
4
Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.局限性肌层浸润性膀胱癌的大分割放疗综述
Crit Rev Oncol Hematol. 2019 Oct;142:76-85. doi: 10.1016/j.critrevonc.2019.06.010. Epub 2019 Jul 16.
5
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).术前短程放疗与长程放化疗治疗直肠T3腺癌的随机试验中的急性不良事件和术后并发症：跨塔斯曼放射肿瘤学组试验（TROG 01.04）
Ann Surg. 2017 May;265(5):882-888. doi: 10.1097/SLA.0000000000001987.
6
Surgery versus radiotherapy for muscle invasive bladder cancer?
Clin Oncol (R Coll Radiol). 2003 May;15(3):167-8. doi: 10.1053/clon.2003.0227.
7
Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015).浸润性膀胱癌同期放化疗后生活质量评估：多中心前瞻性研究（GETUG 97-015）结果。
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):172-8. doi: 10.1016/j.ijrobp.2009.10.038. Epub 2010 Apr 10.
8
Bladder cancer clinical trials.膀胱癌临床试验。
Urol Oncol. 2005 Jul-Aug;23(4):275-9. doi: 10.1016/j.urolonc.2005.05.005.
9
Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial.卡波金与烟酰胺用于局部晚期膀胱癌：一项III期随机试验的早期结果
Radiother Oncol. 2009 Apr;91(1):120-5. doi: 10.1016/j.radonc.2008.10.001. Epub 2008 Nov 5.
10
Is there a role for radiation therapy in the treatment of invasive bladder cancer?
J Urol. 1997 May;157(5):1647-8. doi: 10.1016/s0022-5347(01)64820-1.
引用本文的文献
1
Quality of Life following Chemoradiotherapy for Localized Muscle Invasive Bladder Carcinoma: A Systematic Review.局部肌层浸润性膀胱癌放化疗后的生活质量：一项系统评价
Bladder Cancer. 2021 Dec 13;7(4):463-475. doi: 10.3233/BLC-210011. eCollection 2021.
Zotero 插件